Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cancer in dyskeratosis congenita.

Alter BP, Giri N, Savage SA, Rosenberg PS.

Blood. 2009 Jun 25;113(26):6549-57. doi: 10.1182/blood-2008-12-192880. Epub 2009 Mar 12. Review.

2.

Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.

Rosenberg PS, Alter BP, Ebell W.

Haematologica. 2008 Apr;93(4):511-7. doi: 10.3324/haematol.12234. Epub 2008 Mar 5.

3.

Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS.

Br J Haematol. 2010 Jul;150(2):179-88. doi: 10.1111/j.1365-2141.2010.08212.x. Epub 2010 Apr 30.

4.

Cancer incidence in persons with Fanconi anemia.

Rosenberg PS, Greene MH, Alter BP.

Blood. 2003 Feb 1;101(3):822-6. Epub 2002 Sep 5. Erratum in: Blood. 2003 Mar 15;101(6):2136.

5.

Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.

Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM.

Blood. 2012 Apr 19;119(16):3815-9. doi: 10.1182/blood-2011-08-375972. Epub 2012 Feb 23.

6.

Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology?

Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, Savage SA.

Psychosomatics. 2012 May-Jun;53(3):230-5. doi: 10.1016/j.psym.2011.09.003. Epub 2012 Mar 27.

7.

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E.

N Engl J Med. 1993 Oct 14;329(16):1152-7.

8.

Telomere length in inherited bone marrow failure syndromes.

Alter BP, Giri N, Savage SA, Rosenberg PS.

Haematologica. 2015 Jan;100(1):49-54. doi: 10.3324/haematol.2014.114389. Epub 2014 Oct 10.

9.

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.

Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I.

Blood. 2008 Nov 1;112(9):3594-600. doi: 10.1182/blood-2008-05-153445. Epub 2008 Jul 30.

10.

Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.

Tamary H, Nishri D, Yacobovich J, Zilber R, Dgany O, Krasnov T, Aviner S, Stepensky P, Ravel-Vilk S, Bitan M, Kaplinsky C, Ben Barak A, Elhasid R, Kapelusnik J, Koren A, Levin C, Attias D, Laor R, Yaniv I, Rosenberg PS, Alter BP.

Haematologica. 2010 Aug;95(8):1300-7. doi: 10.3324/haematol.2009.018119. Epub 2010 Apr 30.

11.

Response to androgen therapy in patients with dyskeratosis congenita.

Khincha PP, Wentzensen IM, Giri N, Alter BP, Savage SA.

Br J Haematol. 2014 May;165(3):349-57. doi: 10.1111/bjh.12748. Epub 2014 Feb 12.

12.

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R.

Blood. 1996 Jan 1;87(1):386-92.

13.

Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.

Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP.

Ophthalmology. 2010 Mar;117(3):615-22. doi: 10.1016/j.ophtha.2009.08.023. Epub 2009 Dec 22.

14.

Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.

Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA.

Haematologica. 2012 Mar;97(3):353-9. doi: 10.3324/haematol.2011.055269. Epub 2011 Nov 4.

15.

Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Vulliamy TJ, Knight SW, Mason PJ, Dokal I.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):353-7.

PMID:
11259155
16.

Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Gadalla SM, Wang T, Haagenson M, Spellman SR, Lee SJ, Williams KM, Wong JY, De Vivo I, Savage SA.

JAMA. 2015 Feb 10;313(6):594-602. doi: 10.1001/jama.2015.7.

17.

Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.

Imai J, Suzuki T, Yoshikawa M, Dekiden M, Nakae H, Nakahara F, Tsuda S, Mizukami H, Koike J, Igarashi M, Yabe H, Mine T.

Intern Med. 2016;55(23):3441-3444. Epub 2016 Dec 1.

18.

Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Sklavos MM, Stratton P, Giri N, Alter BP, Savage SA, Pinto LA.

J Clin Endocrinol Metab. 2015 Feb;100(2):E197-203. doi: 10.1210/jc.2014-2838. Epub 2014 Nov 18.

19.

Recent progress in dyskeratosis congenita.

Nishio N, Kojima S.

Int J Hematol. 2010 Oct;92(3):419-24. doi: 10.1007/s12185-010-0695-5. Epub 2010 Oct 1. Review.

PMID:
20882440
20.

Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus.

Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M.

Int J Cancer. 2013 Sep 15;133(6):1513-5. doi: 10.1002/ijc.28157. Epub 2013 Apr 5.

Supplemental Content

Support Center